Latest News
⭐ We are pleased to announce that company has received the approval from the General Directorate of Medicines, Supplies and Drugs (DIGEMID), Peru for it's Generic, Injectable & OSD (Unit-1 in Amritsar) and for Oncology, Injectable & OSD (Unit-3 in Himachal Pradesh)
Contact Us
FOR ORDERS
Ibm@kwalitypharma.com
+91 9779177677
FOR QUERY
info@kwalitypharma.com
+91 7657833389
FOR JOBS
hrd@kwalitypharma.com
+91 9888014228
Customer Enquiry
Company Brochure
360°
Product View
Great
Place
To
Work
®
Certified
SEP 2026-SEP 2027
INDIA
Home
About
Facilities
Gallery
Investor Relations
Job Opportunities
Online Enquiry
Financial Statements of Subsidiary companies
Financial Statements of Subsidiary companies
Financials for 31-03-2026
Financials for 31-03-2024
Financials for 31-03-2023
Financials for 31-03-2022
Financials for 31-03-2021
Financials for 31-03-2020
Financials for 31-03-2019
Financial Results
Financial Results for Half Year Ended 30-09-2019
Financial Results for the Half Year and Year Ended 31-03-2019
Financial Results for Half Year Ended 30-09-2020
Financial Results Half Year and Year Ended 31-03-2020
Financial Results for Half Year Ended 30-09-2021
Financial Results for Half Year and Year Ended 31-03-2021
Financial Results for Quarter Ended 31-12-2022
Financial Results for quarter ended 30-09-2022
Financial Results for Quarter Ended 30-06-2022
Finanicial Results for Half Year and Year Ended 31-03-2022
Notice of Board Meeting
Notice of Board Meeting 14-11-2019
Notice of Board Meeting 30-05-2019
Notice of Board Meeting 13-11-2020
Notice of Board Meeting 13-07-2020
Notice of Board Meeting 22-10-2021
Notice of Board Meeting 30-06-2021
Notice of Board Meeting 06-02-2023
Notice of Board Meeting 14-11-2022
Notice of Board Meeting 13-08-2022
Notice of Board Meeting 18-05-2022
